COVID-19 vaccination in Bangladesh (original) (raw)

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized for emergency use from January to April 2021. Bangladesh ordered vaccines produced by Serum Institute of India, however it delivered less than half of the doses as agreed to Bangladesh. After the vaccine shortage due to this, Bangladesh approved the Russian Sputnik V and Chinese Sinopharm BIBP vaccines for emergency use in late April 2021. Bangladesh has also authorized the emergency use of Pfizer–BioNTech COVID-19 vaccine to be distributed as part of COVAX. It was reported that the Bangladesh government planned to give permission to Bangladeshi made Bangavax developed by Globe Biotech Ltd. to